Login / Signup

Landscape of phase 1 clinical trials for minors with cancer in the United States.

Jaclynne H NaderDylan V NeelDavid S ShulmanClement MaFlorence BourgeoisSteven G DuBois
Published in: Pediatric blood & cancer (2020)
The paucity of clear temporal trends highlights the need for innovation in early drug development for young people. Our analysis serves as a benchmark against which to evaluate initiatives to improve pediatric cancer drug development.
Keyphrases
  • papillary thyroid
  • clinical trial
  • squamous cell
  • childhood cancer
  • lymph node metastasis
  • single cell
  • randomized controlled trial
  • quality improvement
  • young adults